08:50 AM EDT, 09/17/2025 (MT Newswires) -- BioAffinity Technologies ( BIAF ) said Wednesday that it will implement a 1-for-30 reverse stock split of its common stock.

The split-adjusted shares will begin trading on the Nasdaq Capital Market on Friday and is intended to comply with the minimum bid price requirement, the company said.

The split will also result in proportionate adjustments to the exercise prices and share counts of outstanding stock options and warrants, BioAffinity ( BIAF ) said.

Shares of the company were down 23% in recent Wednesday premarket activity.